Viridian Therapeutic (VRDN) PT Lowered to $36 at Goldman Sachs
Goldman Sachs analyst Richard Law ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)